Michigan PDAB

Information, updates, and engagement opportunities related to the
Prescription Drug Affordability Board (PDAB).

Statute:

Pending before the Michigan Legislature, SB483

PDAB (includes public meeting notices):

Michigan has not yet established a Prescription Drug Affordability Board. CANN tracks proposed and pending legislation in Michigan and will update this page as the state's posture changes.

Public Comments

Letters and testimony submitted regarding state PDAB activity

CANN Public Comment: Michigan SB 3, SB 4, SB 5 — PDAB Legislation

Publication date:

4/22/25

Comment opposing Michigan's PDAB bills (SB 3, SB 4, SB 5), citing inadequate cost-benefit analysis, PBM pricing manipulation issues, and risks to safety-net programs without patient-centered reforms.

View PDF

CANN Letter: Michigan SB 483 Opposition

Publication date:

10/20/23

Letter opposing Michigan SB 483 establishing a PDAB, highlighting Colorado PDAB process failures and recommending patient-centered amendments for any future legislation.

View PDF

CANN Written Testimony: Michigan SB 483

Publication date:

9/19/23

Testimony opposing Michigan SB 483, recommending amendments to prioritize patient representation, define therapeutic alternatives, and protect 340B-dependent programs.

View PDF